Department of Oral Pathology, Faculty of Dentistry, Damascus University, Damascus, Syria.
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3471-3479. doi: 10.31557/APJCP.2024.25.10.3471.
Immune checkpoint proteins, especially PD-1/PD-L1, play a vital role in controlling the intensity and duration of the immune response. However, cancer cells often over-expression PDL-1 on their surfaces, which leads to the permanent activation of the PD-1/PDL-1 pathway and exhaustion of T cells and creates a resistant tumor microenvironment. This study aimed to analyze PD-1, PD-L1 expression in tumor cells (PDL-1/TC) and in Tumor-Infiltrating Lymphocytes (PDL-1/TILS) of OSCC patients and associated with and to correlate it with histologic grade of malignancy and clinicopathologic parameters.
The sample consisted of 43 archived specimens of 43 patients of OSCC with Clinical features (gender, age, smoking, clinical stage) collected from medical records between 2014-2021. The intensity of PD-1, PDL-1/TC, PDL-1/TILS, positive cells were assessed by immunohistochemistry.
PDL-1/TILS and PDL-1/TC were observed in all specimens except two cases in well-differentiated were negative. PDL-1/TILS was significant between histological grades(P=0.004<0.05). There was no significant between PDL-1/TC and PDL-1/TILS and between poorly differentiated and moderately differentiated groups' ROC P values (P=0.133, 0.340>0.05) respectively. There is a difference between PDL-1/TC and PDL-1/TILS between poorly differentiated and well-differentiated groups ROC P value (0.005, 0.028), Sensitivity (0.857, 0.857), specificity (0.765, 0.824) respectively and there is a difference between and PDL-1/TILS moderate differentiated and well-differentiated groups ROC P value (0.133,) Sensitivity (0.737), specificity (0.765). No differences between PDL-1/TC and moderate and well-differentiated groups P value (0.173). There is a significant correlation between PDL-1/TC and PDL-1/TILS with an age P>65 value (0.032) in the well-differentiated group. PDL-1/TC and PDL-1/TILS with the depth of invasion (DOI) in the well-differentiated group. No significant correlation was obtained between PDL-1/TC and PDL-1/TILS and smoking, clinical stage, and gender. No significant correlation was obtained between PD1 and the histological grades or clinicopathologic characteristics.
PDL-1/TILS and PDL-1/TC are independent prognostic factors in OSCC and PDL1-/TILS has an important role.
免疫检查点蛋白,尤其是 PD-1/PD-L1,在控制免疫反应的强度和持续时间方面起着至关重要的作用。然而,癌细胞表面常常过度表达 PDL-1,导致 PD-1/PDL-1 通路的永久激活和 T 细胞耗竭,并形成抵抗肿瘤的微环境。本研究旨在分析 OSCC 患者肿瘤细胞(PDL-1/TC)和肿瘤浸润淋巴细胞(PDL-1/TILS)中 PD-1、PD-L1 的表达,并与组织学恶性程度和临床病理参数相关联。
该样本由 2014 年至 2021 年间从病历中收集的 43 例 OSCC 患者的 43 份存档标本组成,具有临床特征(性别、年龄、吸烟、临床分期)。通过免疫组织化学评估 PD-1、PDL-1/TC、PDL-1/TILS、阳性细胞的强度。
除了 2 例分化良好的病例为阴性外,所有标本中均观察到 PDL-1/TILS 和 PDL-1/TC。PDL-1/TILS 在组织学分级之间有显著差异(P=0.004<0.05)。PDL-1/TC 和 PDL-1/TILS 之间以及低分化和中分化组的 ROC P 值之间无显著差异(P=0.133,0.340>0.05)。低分化和高分化组之间的 PDL-1/TC 和 PDL-1/TILS 之间的 ROC P 值(0.005,0.028)、灵敏度(0.857,0.857)、特异性(0.765,0.824)存在差异,PDL-1/TILS 与中分化和高分化组之间的 ROC P 值(0.133)、灵敏度(0.737)、特异性(0.765)存在差异。PDL-1/TC 和中分化和高分化组之间的 P 值(0.173)之间无差异。在分化良好的组中,PDL-1/TC 和 PDL-1/TILS 与年龄>65 岁的 P 值之间存在显著相关性(0.032)。在分化良好的组中,PDL-1/TC 和 PDL-1/TILS 与浸润深度(DOI)之间存在显著相关性。PDL-1/TC 和 PDL-1/TILS 与吸烟、临床分期和性别之间未获得显著相关性。PD1 与组织学分级或临床病理特征之间未获得显著相关性。
PDL-1/TILS 和 PDL-1/TC 是 OSCC 的独立预后因素,PDL1-/TILS 具有重要作用。